Related Experiment Videos
DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14
Estella A Koppel1, Eirikur Saeland, Désirée J M de Cooker
1Department of Molecular Cell Biology & Immunology, VU University Medical Center Amsterdam, v.d. Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.
Immunobiology
|September 17, 2005
Summary
Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) specifically binds Streptococcus pneumoniae serotypes 3 and 14. This interaction, though not immunomodulatory, offers potential for novel vaccine development against pneumococcal disease.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Streptococcus pneumoniae causes community-acquired pneumonia and antibiotic resistance is increasing.
- Understanding host-pathogen interactions is crucial for effective treatment and vaccine development.
- Dendritic cells (DCs) use receptors like DC-SIGN for pathogen recognition, a key step in immune response induction.
Purpose of the Study:
- To investigate the in vitro binding of DC-SIGN with Streptococcus pneumoniae.
- To identify specific S. pneumoniae serotypes that interact with DC-SIGN.
- To explore the potential implications of DC-SIGN interaction in pneumococcal pathogenesis and vaccine strategies.
Main Methods:
- In vitro binding assays were performed to assess the interaction between DC-SIGN and various S. pneumoniae serotypes.
- Ligand identification for DC-SIGN binding was explored, focusing on capsular polysaccharides.
- Immunomodulatory effects of the interaction on dendritic cells were evaluated.
Main Results:
- DC-SIGN specifically binds to S. pneumoniae serotypes 3 and 14, but not to serotype 19F.
- Binding to serotype 14 involves a ligand expressed by the capsular polysaccharide.
- Binding to serotype 3 involves an unidentified ligand.
- No immunomodulatory effects on dendritic cells were observed despite the binding of S. pneumoniae serotype 14 to DC-SIGN.
Conclusions:
- DC-SIGN exhibits serotype-specific binding to Streptococcus pneumoniae.
- The interaction mechanism for serotype 3 binding requires further elucidation.
- While direct immunomodulation was not observed, the serotype-specific interaction with DC-SIGN warrants further investigation for potential vaccine development against pneumococcal infections.